BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20879565)

  • 1. Effects of breast-air and breast-lung interfaces on the dose rate at the planning target volume of a MammoSite catheter for Yb-169 and Ir-192 HDR sources.
    Cazeca MJ; Medich DC; Munro JJ
    Med Phys; 2010 Aug; 37(8):4038-45. PubMed ID: 20879565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dosimetric comparison of 169Yb and 192Ir for HDR brachytherapy of the breast, accounting for the effect of finite patient dimensions and tissue inhomogeneities.
    Lymperopoulou G; Papagiannis P; Angelopoulos A; Karaiskos P; Georgiou E; Baltas D
    Med Phys; 2006 Dec; 33(12):4583-9. PubMed ID: 17278810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetry of MammoSite® applicator: comparison between Monte Carlo simulation, measurements, and treatment planning calculation.
    Oshaghi M; Sadeghi M; Mahdavi SR; Shirazi A
    J Cancer Res Ther; 2013; 9(2):224-9. PubMed ID: 23771363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated partial breast irradiation: a dosimetric comparison of three different techniques.
    Weed DW; Edmundson GK; Vicini FA; Chen PY; Martinez AA
    Brachytherapy; 2005; 4(2):121-9. PubMed ID: 15893265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the use of HDR 60Co source with the MammoSite radiation therapy system.
    Baltas D; Lymperopoulou G; Zamboglou N
    Med Phys; 2008 Dec; 35(12):5263-8. PubMed ID: 19175085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of organ doses for patients undergoing balloon brachytherapy of the breast with HDR 192Ir or electronic sources using monte carlo simulations in a heterogeneous human phantom.
    Mille MM; Xu XG; Rivard MJ
    Med Phys; 2010 Feb; 37(2):662-71. PubMed ID: 20229875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast effects on dosimetry of a partial breast irradiation system.
    Kassas B; Mourtada F; Horton JL; Lane RG
    Med Phys; 2004 Jul; 31(7):1976-9. PubMed ID: 15305449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of source position uncertainties & balloon deformation in MammoSite brachytherapy on treatment effectiveness.
    Bensaleh S; Bezak E
    Australas Phys Eng Sci Med; 2010 Mar; 33(1):35-44. PubMed ID: 20300986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric assessment of an air-filled balloon applicator in HDR vaginal cuff brachytherapy using the Monte Carlo method.
    Jiang H; Badkul R; Pokhrel D
    J Appl Clin Med Phys; 2018 May; 19(3):101-107. PubMed ID: 29493101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurements of dose discrepancies due to inhomogeneities and radiographic contrast in balloon catheter brachytherapy.
    Oh S; Scott J; Shin DH; Suh TS; Kim S
    Med Phys; 2009 Sep; 36(9):3945-54. PubMed ID: 19810467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the use of high dose rate 192Ir and 169Yb sources with the MammoSite radiation therapy system.
    Papagiannis P; Karaiskos P; Georgiou E; Baltas D; Lymperopoulou G; Pantelis E; Sakelliou L
    Med Phys; 2007 Sep; 34(9):3614-9. PubMed ID: 17926965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direction modulated brachytherapy (DMBT) for treatment of cervical cancer: A planning study with
    Safigholi H; Han DY; Mashouf S; Soliman A; Meigooni AS; Owrangi A; Song WY
    Med Phys; 2017 Dec; 44(12):6538-6547. PubMed ID: 28940520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources.
    Krishnamurthy D; Weinberg V; Cunha JA; Hsu IC; Pouliot J
    Brachytherapy; 2011; 10(6):461-5. PubMed ID: 21397569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A CT-based analytical dose calculation method for HDR 192Ir brachytherapy.
    Poon E; Verhaegen F
    Med Phys; 2009 Sep; 36(9):3982-94. PubMed ID: 19810471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric characterization of round HDR 192Ir accuboost applicators for breast brachytherapy.
    Rivard MJ; Melhus CS; Wazer DE; Bricault RJ
    Med Phys; 2009 Nov; 36(11):5027-32. PubMed ID: 19994513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monte Carlo characterization of a new Yb-169 high dose rate source for brachytherapy application.
    Cazeca MJ; Medich DC; Munro JJ
    Med Phys; 2010 Mar; 37(3):1129-36. PubMed ID: 20384248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose perturbations due to contrast medium and air in mammosite treatment: an experimental and Monte Carlo study.
    Cheng CW; Mitra R; Li XA; Das IJ
    Med Phys; 2005 Jul; 32(7):2279-87. PubMed ID: 16121583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of rib and lung heterogeneities on the computed dose to lung in Ir-192 high-dose-rate breast brachytherapy: Monte Carlo versus a treatment planning system.
    Yazdi HS; Shamsaei M; Jaberi R; Shabani HR; Allahverdi M; Vaezzadeh SA
    J Cancer Res Ther; 2012; 8(3):394-8. PubMed ID: 23174721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism.
    Ballester F; Carlsson Tedgren Å; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith RL; Thomson RM; Verhaegen F; Vijande J; Ma Y; Beaulieu L
    Med Phys; 2015 Jun; 42(6):3048-61. PubMed ID: 26127057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of finite patient dimensions and tissue inhomogeneities on dosimetry planning of 192Ir HDR breast brachytherapy: a Monte Carlo dose verification study.
    Pantelis E; Papagiannis P; Karaiskos P; Angelopoulos A; Anagnostopoulos G; Baltas D; Zamboglou N; Sakelliou L
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1596-602. PubMed ID: 15817368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.